We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.03%
3 Healthcare 14.17%
4 Industrials 13.91%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTO
501
DELISTED
Vista Outdoor Inc.
VSTO
$440K 0.07%
18,533
+4,037
+28% +$86.1K
PVH icon
502
PVH
PVH
$4.04B
$439K 0.07%
4,676
-875
-16% -$66.6K
ATNX
503
DELISTED
Athenex, Inc. Common Stock
ATNX
$439K 0.07%
+1,986
New +$489K
DCH
504
Dauch Corp
DCH
$1.51B
$438K 0.07%
52,472
-22,822
-30% -$172K
GE icon
505
GE Aerospace
GE
$384B
$437K 0.07%
+8,126
New +$364K
MSTR icon
506
Strategy Inc
MSTR
$38.4B
$437K 0.07%
+11,240
New +$262K
WSBC icon
507
WesBanco
WSBC
$4B
$435K 0.07%
14,522
+3,882
+36% +$105K
HMSY
508
DELISTED
HMS Holdings Corp.
HMSY
$435K 0.07%
+11,826
New +$359K
UFS
509
DELISTED
DOMTAR CORPORATION (New)
UFS
$435K 0.07%
13,750
-7,076
-34% -$201K
PB icon
510
Prosperity Bancshares
PB
$8.89B
$434K 0.07%
6,255
+930
+17% +$57K
DRNA
511
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$434K 0.07%
19,688
-4,700
-19% -$104K
FDX icon
512
FedEx
FDX
$75.4B
$433K 0.07%
1,667
+353
+27% +$97.8K
GERN icon
513
Geron
GERN
$949M
$433K 0.07%
272,296
+241,430
+782% +$440K
GNSS icon
514
Genasys
GNSS
$79.2M
$433K 0.07%
66,446
+39,120
+143% +$252K
EGLE
515
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$433K 0.07%
+22,797
New +$396K
PLNT icon
516
Planet Fitness
PLNT
$3.78B
$432K 0.07%
+5,566
New +$389K
KALV
517
DELISTED
KalVista Pharmaceuticals
KALV
$430K 0.07%
22,664
-2,802
-11% -$48.1K
OPLN
518
Openlane
OPLN
$4.54B
$430K 0.07%
23,083
+4,281
+23% +$73.9K
SCS
519
DELISTED
Steelcase
SCS
$428K 0.07%
31,613
-45,897
-59% -$562K
DLB icon
520
Dolby
DLB
$5.79B
$427K 0.07%
4,397
-9,995
-69% -$826K
RARE icon
521
Ultragenyx Pharmaceutical
RARE
$2.55B
$427K 0.07%
+3,084
New +$366K
HCCI
522
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$427K 0.07%
20,284
+798
+4% +$14.8K
RRD
523
DELISTED
RR Donnelley & Sons Co.
RRD
$427K 0.07%
+189,094
New +$284K
ARLO icon
524
Arlo Technologies
ARLO
$1.65B
$426K 0.07%
54,647
+27,306
+100% +$166K
PLUG icon
525
Plug Power
PLUG
$3.04B
$426K 0.07%
12,573
-7,351
-37% -$166K

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.